TCR alpha/beta Antibody (BMA031) - Chimeric
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-43550
Recombinant Monoclonal Antibody
Key Product Details
Species Reactivity
Human
Applications
Block/Neutralize, Immunocytochemistry/ Immunofluorescence, Immunoprecipitation, Serum
Label
Unconjugated
Antibody Source
Recombinant Monoclonal Rabbit IgG Clone # BMA031
Concentration
1 mg/ml
Product Specifications
Immunogen
The original antibody was generated by immunizing mice with human perihperal blood T-lymphocytes.
Specificity
This antibody reacts with surface receptors on all alpha-beta TCR alpha/beta bearing cells, but does not react with receptors on gamma-delta T cells. TCR alpha/beta-alphabeta is expressed by the majority of mature CD3+ T cells.
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Description
This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques.
Applications for TCR alpha/beta Antibody (BMA031) - Chimeric
Application
Recommended Usage
Serum
FACS
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS
Preservative
0.02% Proclin 300
Concentration
1 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: TCR alpha/beta
Alternate Names
C), D, FLJ22602, J, MGC117436, MGC22624, MGC23964, MGC71411, T cell receptor alpha locus, T-cell antigen receptor, alpha polypeptide, T-cell receptor, alpha (V, TCRA, TCRD, TRA
Gene Symbol
TRA
Additional TCR alpha/beta Products
Product Documents for TCR alpha/beta Antibody (BMA031) - Chimeric
Product Specific Notices for TCR alpha/beta Antibody (BMA031) - Chimeric
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...